180 related articles for article (PubMed ID: 28246926)
1. Romosozumab Treatment Converts Trabecular Rods into Trabecular Plates in Male Cynomolgus Monkeys.
Matheny JB; Torres AM; Ominsky MS; Hernandez CJ
Calcif Tissue Int; 2017 Jul; 101(1):82-91. PubMed ID: 28246926
[TBL] [Abstract][Full Text] [Related]
2. Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys.
Boyce RW; Niu QT; Ominsky MS
Bone; 2017 Aug; 101():77-87. PubMed ID: 28428078
[TBL] [Abstract][Full Text] [Related]
3. Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment.
Chavassieux P; Chapurlat R; Portero-Muzy N; Roux JP; Garcia P; Brown JP; Libanati C; Boyce RW; Wang A; Grauer A
J Bone Miner Res; 2019 Sep; 34(9):1597-1608. PubMed ID: 31233639
[TBL] [Abstract][Full Text] [Related]
4. Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis.
Graeff C; Campbell GM; Peña J; Borggrefe J; Padhi D; Kaufman A; Chang S; Libanati C; Glüer CC
Bone; 2015 Dec; 81():364-369. PubMed ID: 26232375
[TBL] [Abstract][Full Text] [Related]
5. Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody.
Ominsky MS; Niu QT; Li C; Li X; Ke HZ
J Bone Miner Res; 2014 Jun; 29(6):1424-30. PubMed ID: 24967455
[TBL] [Abstract][Full Text] [Related]
6. Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys.
Ominsky MS; Boyd SK; Varela A; Jolette J; Felx M; Doyle N; Mellal N; Smith SY; Locher K; Buntich S; Pyrah I; Boyce RW
J Bone Miner Res; 2017 Apr; 32(4):788-801. PubMed ID: 27865001
[TBL] [Abstract][Full Text] [Related]
7. Romosozumab in postmenopausal women with low bone mineral density.
McClung MR; Grauer A; Boonen S; Bolognese MA; Brown JP; Diez-Perez A; Langdahl BL; Reginster JY; Zanchetta JR; Wasserman SM; Katz L; Maddox J; Yang YC; Libanati C; Bone HG
N Engl J Med; 2014 Jan; 370(5):412-20. PubMed ID: 24382002
[TBL] [Abstract][Full Text] [Related]
8. Finite Element Analysis of Denosumab Treatment Effects on Vertebral Strength in Ovariectomized Cynomolgus Monkeys.
Lee DC; Varela A; Kostenuik PJ; Ominsky MS; Keaveny TM
J Bone Miner Res; 2016 Aug; 31(8):1586-95. PubMed ID: 27149403
[TBL] [Abstract][Full Text] [Related]
9. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength.
Ominsky MS; Vlasseros F; Jolette J; Smith SY; Stouch B; Doellgast G; Gong J; Gao Y; Cao J; Graham K; Tipton B; Cai J; Deshpande R; Zhou L; Hale MD; Lightwood DJ; Henry AJ; Popplewell AG; Moore AR; Robinson MK; Lacey DL; Simonet WS; Paszty C
J Bone Miner Res; 2010 May; 25(5):948-59. PubMed ID: 20200929
[TBL] [Abstract][Full Text] [Related]
10. Anti-sclerostin - is there an indication?
Larsson S
Injury; 2016 Jan; 47 Suppl 1():S31-5. PubMed ID: 26768288
[TBL] [Abstract][Full Text] [Related]
11. Deterioration of trabecular plate-rod and cortical microarchitecture and reduced bone stiffness at distal radius and tibia in postmenopausal women with vertebral fractures.
Wang J; Stein EM; Zhou B; Nishiyama KK; Yu YE; Shane E; Guo XE
Bone; 2016 Jul; 88():39-46. PubMed ID: 27083398
[TBL] [Abstract][Full Text] [Related]
12. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.
Kostenuik PJ; Smith SY; Jolette J; Schroeder J; Pyrah I; Ominsky MS
Bone; 2011 Aug; 49(2):151-61. PubMed ID: 21457806
[TBL] [Abstract][Full Text] [Related]
13. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
Bilezikian JP; Hattersley G; Fitzpatrick LA; Harris AG; Shevroja E; Banks K; Leder BZ; Zanchetta JR; Hans D
Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of sclerostin for post-menopausal osteoporosis therapy: A critical assessment of the mechanism of action.
Bhattacharyya S; Pal S; Chattopadhyay N
Eur J Pharmacol; 2018 May; 826():39-47. PubMed ID: 29476877
[TBL] [Abstract][Full Text] [Related]
15. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques.
Sato M; Westmore M; Clendenon J; Smith S; Hannum B; Zeng GQ; Brommage R; Turner CH
Osteoporos Int; 2000; 11(10):871-80. PubMed ID: 11199192
[TBL] [Abstract][Full Text] [Related]
17. Anti-sclerostin antibodies: utility in treatment of osteoporosis.
Clarke BL
Maturitas; 2014 Jul; 78(3):199-204. PubMed ID: 24842796
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of changes in trabecular bone architecture and mechanical properties of minipig vertebrae by three-dimensional magnetic resonance microimaging and finite element modeling.
Borah B; Dufresne TE; Cockman MD; Gross GJ; Sod EW; Myers WR; Combs KS; Higgins RE; Pierce SA; Stevens ML
J Bone Miner Res; 2000 Sep; 15(9):1786-97. PubMed ID: 10976998
[TBL] [Abstract][Full Text] [Related]
19. Quantification of the roles of trabecular microarchitecture and trabecular type in determining the elastic modulus of human trabecular bone.
Liu XS; Sajda P; Saha PK; Wehrli FW; Guo XE
J Bone Miner Res; 2006 Oct; 21(10):1608-17. PubMed ID: 16995816
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
Stolina M; Dwyer D; Niu QT; Villasenor KS; Kurimoto P; Grisanti M; Han CY; Liu M; Li X; Ominsky MS; Ke HZ; Kostenuik PJ
Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
